Curcumin Phytosome - Sustained Release 120c by Thorne
(formerly Meriva-SF)
Curcumin Phytosome - Sustained Release by Thorne is a unique, patented sustained-release curcumin supplement that is soy free. Curcumin, the orange pigment in turmeric (curry s primary ingredient), is a potent antioxidant that may provide several health benefits, including supporting cardiovascular, GI, and hepatic function and joint health, by helping maintain normal inflammatory response in the body through the optimization of the production of cytokines. *
- Curcumin bound to sunflower phospholipids especially for sensitive patients
- Phytosome technology ensures more efficient absorption*
- May help maintain a healthy balance of cytokines in the body*
- Provides antioxidant support*
- May provide relief from occasional stiffness and soreness*
- Research has suggested Curcumin Phytosome - Sustained Release can provide support for joint, muscle, eye, GI tract, liver, prostate, and nerve health and can provide nutritional support to oncology patients*
Recommendation:
Thorne suggests taking 1-2 capsules two times daily or as recommended by your healthcare practitioner.
Serving Size: 2 Capsules
Servings Per Container: 60
Amount Per Serving:
Curcumin Phytosome 500mg
(Curcuma longa extract (root)
/ Phospholipid complex from Sunflower)
Other Ingredients: High and low viscosity hydroxypropyl methylcellulose and Calcium Citrate Laurate, Hypromellose (derived from cellulose) capsule, Leucine, Silicon Dioxide, Microcrystalline Cellulose.
ALLERGY WARNING
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
PREGNANCY
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
PREGNANCY
If pregnant, consult your health professional before using this product.
INTERACTIONS
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.
INTERACTIONS
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.
Curcumin Phytosome (Meriva) complexed with Time-Sorb, a time-release matrix. This product uses Indena S.p.A. s curcumin phytosome (Meriva). Meriva is a registered trademark of Indena S.p.A.